smjStrategies, Inc.

Sorry, but this listing is on a subscription plan which does not allow users to contact them via email

Sorry, but we don't have a location for this listing

Sorry, but we don't have a phone number for this listing

Sorry, but this listing is on a subscription plan which does not allow users to schedule meetings with them

Sorry, but this listing is on a subscription plan which does not allow users to view their website URL

Revolutionizing Drug Development Through Firsthand Clinical Trial Experience

Operating at the forefront of drug development, this pioneering company is committed to revolutionizing how information about pharmaceuticals is gathered and utilized. With an extensive portfolio of original research, the company aims to bridge the gap between drug development professionals and the clinical trial process. By enabling these professionals to gain firsthand experience as clinical trial subjects, they are shifting the paradigm within the pharmaceutical industry, fostering deeper insights, and enhancing job performance.

One noteworthy initiative includes the "Pharma as Patients" project, a collaboration with Brenner Insights, which is the first to systematically measure the participation of drug development professionals in clinical trials. This innovative approach aspires to establish a new standard for the industry, enabling those who design clinical trials to directly engage in them, thereby potentially accelerating research and development. The company's dedication to fostering a more integrative and experiential understanding of the patient journey is a testament to its role as a leader in drug information.

Revolutionizing Drug Development Through Firsthand Clinical Trial Experience

Operating at the forefront of drug development, this pioneering company is committed to revolutionizing how information about pharmaceuticals is gathered and utilized. With an extensive portfolio of original research, the company aims to bridge the gap between drug development professionals and the clinical trial process. By enabling these professionals to gain firsthand experience as clinical trial subjects, they are shifting the paradigm within the pharmaceutical industry, fostering deeper insights, and enhancing job performance.

One noteworthy initiative includes the "Pharma as Patients" project, a collaboration with Brenner Insights, which is the first to systematically measure the participation of drug development professionals in clinical trials. This innovative approach aspires to establish a new standard for the industry, enabling those who design clinical trials to directly engage in them, thereby potentially accelerating research and development. The company's dedication to fostering a more integrative and experiential understanding of the patient journey is a testament to its role as a leader in drug information.

Show More

Recommendations (0)

All (0)
Recommendations (0)
Reviews (0)
Videos (0)
No data found